Hybridoma technology is used to produce monoclonal antibodies, not polyclonal antibodies.
(A) is correct because hybridoma cells survive in HAT medium by using hypoxanthine and thymidine.
(B) is correct because aminopterin blocks de novo DNA synthesis in myeloma cells.
(D) is correct since PEG is used for cell fusion.
Therefore, the only incorrect statement is that hybridomas produce polyclonal antibodies.